The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
59 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $128,664,884 in first-year total cost, median $2,146,256.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RPRB-L (M1)]8
- Special Emphasis Panel[ZCA1 RPRB-H (J1)]7
- Special Emphasis Panel[ZCA1 RPRB-J (M1)]4
- Special Emphasis Panel[ZCA1 RPRB-L (J1)]4
- Special Emphasis Panel[ZCA1 RPRB-L (O1)]4
Most frequent institutions
- UNIVERSITY OF PENNSYLVANIA5
- STANFORD UNIVERSITY4
- UNIVERSITY OF MINNESOTA4
- BAYLOR COLLEGE OF MEDICINE3
- DANA-FARBER CANCER INST3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Targeting Replication Stress and DNA Damage Response in Uterine Cancer1P01CA269021-01A1 | KONSTANTINOPOULOS, PANAGIOTISLIU, JOYCEMATULONIS, URSULA ANNE | DANA-FARBER CANCER INST, MA | $2,971,802 | ZCA1 |
| 2024 | Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance2P01CA217959-06A1 | MARIS, JOHN M | CHILDREN'S HOSP OF PHILADELPHIA, PA | $2,545,516 | ZCA1 |
| 2024 | Leveraging Observational (Real World) Data to Advance Precision Oncology1P01CA275746-01A1 | SAWYERS, CHARLES L. | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,372,456 | ZCA1 |
| 2024 | Molecular Biology and Genetics of Human Tumor Viruses2P01CA022443-46A1 | LAMBERT, PAUL F. | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,069,205 | ZCA1 |
| 2024 | Genetic Variation in Cancer Risk and Outcomes in African Americans1P01CA272239-01A1 | BEEBE-DIMMER, JENNIFER LSCHWARTZ, ANN G. | WAYNE STATE UNIVERSITY, MI | $1,919,811 | ZCA1 |
| 2024 | H. pylori-induced Inflammation and Gastric Cancer2P01CA116087-17 | PEEK, RICHARD M. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $1,723,815 | ZCA1 |
| 2023 | Myeloproliferative Neoplasms-Research Consortium2P01CA108671-15 | HOFFMAN, RONALD | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $4,114,819 | ZCA1 |
| 2023 | Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma1P01CA265762-01A1 | HUNTER, TONY R. | SALK INSTITUTE FOR BIOLOGICAL STUDIES, CA | $2,953,179 | ZCA1 |
| 2023 | Integrative Analysis of Lung Cancer Etiology and Risk2U19CA203654-07 | AMOS, CHRISTOPHER I.HUNG, RAYJEAN J.JOHANSSON, MATTIAS ALEXANDERLIN, XIHONG | BAYLOR COLLEGE OF MEDICINE, TX | $2,910,518 | ZCA1 |
| 2023 | Targeting Transcription and Splicing in Cancer2P01CA013106-51 | VAKOC, CHRISTOPHER | COLD SPRING HARBOR LABORATORY, NY | $2,880,000 | ZCA1 |
| 2023 | Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 192P01CA214278-06A1 | JUNE, CARL H. | UNIVERSITY OF PENNSYLVANIA, PA | $2,782,255 | ZCA1 |
| 2023 | Transcription and Replication of Oncogenic Viruses in Hypoxia1P01CA281867-01 | ROBERTSON, ERLE S. | UNIVERSITY OF PENNSYLVANIA, PA | $2,696,989 | ZCA1 |
| 2023 | The I SPY 2.2 TRIAL: Evolving to Imaging and Molecular Biomarker Response Directed Adaptive Sequential Treatment to Optimize Breast Cancer Outcomes2P01CA210961-06A1 | ESSERMAN, LAURA JHYLTON-WATSON, NOLA M. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,689,478 | ZCA1 |
| 2023 | Imaging, Dosimetry and Radiobiology for α-particle Emitter Radiopharmaceutical Therapy1P01CA272222-01A1 | SGOUROS, GEORGE | JOHNS HOPKINS UNIVERSITY, MD | $2,623,913 | ZCA1 |
| 2023 | Integrative Oncogenomics of Multiple Myeloma2P01CA155258-11 | MUNSHI, NIKHIL C. | DANA-FARBER CANCER INST, MA | $2,498,796 | ZCA1 |
| 2023 | Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers1P01CA269043-01A1 | LIEBERMAN, PAUL M. | WISTAR INSTITUTE, PA | $2,436,054 | ZCA1 |
| 2023 | Sex, Chromosomes, and Immunity in Bladder Cancer1P01CA278732-01 | LI, XUE SEAN | CEDARS-SINAI MEDICAL CENTER, CA | $2,272,271 | ZCA1 |
| 2023 | Pathways of Injury and Repair in Barrett's Carcinogenesis1P01CA269019-01A1 | CHAK, AMITABHGUDA, KISHORE | CASE WESTERN RESERVE UNIVERSITY, OH | $2,268,872 | ZCA1 |
| 2023 | Molecular Pathogenesis of the Hamartoma Syndromes2P01CA120964-16 | KWIATKOWSKI, DAVID J. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,168,446 | ZCA1 |
| 2023 | Off-the-Shelf Immune Effector Cells for Hematological Malignancies2P01CA065493-26A1 | WAGNER, JOHN E. | UNIVERSITY OF MINNESOTA, MN | $2,101,526 | ZCA1 |
| 2023 | Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas2P01CA163205-11 | CHIOCCA, E. ANTONIO | BRIGHAM AND WOMEN'S HOSPITAL, MA | $1,883,308 | ZCA1 |
| 2023 | MARVEL: A Multidisciplinary Assessment of Risks from Vaping during Early Life1P01CA269048-01A1 | DONNY, ERIC CHRISTIANSUTFIN, ERIN L | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $1,856,948 | ZCA1 |
| 2023 | Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification1P01CA265772-01A1 | HWANG, JOO HAJI, HANLEE P | STANFORD UNIVERSITY, CA | $1,803,001 | ZCA1 |
| 2023 | Genome Instability Induced Anti-Tumor Immune Responses1P01CA265794-01A1 | GREENBERG, ROGER A | UNIVERSITY OF PENNSYLVANIA, PA | $1,703,863 | ZCA1 |
| 2023 | Therapy-induced cognitive impairment in a rat model of prostate cancer1R01CA285183-01 | MORILAK, DAVID A | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $411,545 | ZCA1 |
| 2022 | Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice2P01CA154292-11 | KERLIKOWSKE, KARLA MMIGLIORETTI, DIANA LTOSTESON, ANNA N. A. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $3,818,184 | ZCA1 |
| 2022 | Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level1P01CA265768-01 | SHEN, MICHAEL M. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $3,052,475 | ZCA1 |
| 2022 | Cellular and Molecular Studies of Bone Marrow Transplant2P01CA039542-33A1 | FERRARA, JAMES L. M. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $2,522,710 | ZCA1 |
| 2022 | Translational Studies in FLASH Particle Radiotherapy1P01CA257904-01A1 | KOUMENIS, CONSTANTINOSLIN, ALEXANDER | UNIVERSITY OF PENNSYLVANIA, PA | $2,478,484 | ZCA1 |
| 2022 | Modifiable Drivers of Expansion and Malignant Transformation from Clonal Hematopoiesis1P01CA265748-01 | GOODELL, MARGARET A. | BAYLOR COLLEGE OF MEDICINE, TX | $2,323,105 | ZCA1 |
| 2022 | Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking2P01CA138338-11 | HECHT, STEPHEN S | UNIVERSITY OF MINNESOTA, MN | $2,243,527 | ZCA1 |
| 2022 | Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)1P01CA257906-01A1 | FU, HAIANRAMALINGAM, SURESH S | EMORY UNIVERSITY, GA | $2,229,253 | ZCA1 |
| 2022 | Molecular Strategies to Widen the Therapeutic Index of Radiotherapy1P01CA257907-01A1 | DIEHN, MAXIMILIANLE, QUYNH-THU XUAN | STANFORD UNIVERSITY, CA | $2,146,256 | ZCA1 |
| 2022 | The Biology of Lung Metastasis in Breast Cancer1P01CA257885-01A1 | BACKER, JONATHAN M. | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $2,014,048 | ZCA1 |
| 2022 | Statistical Methods for Integrative Genomics in Cancer2P01CA196569-07A1 | GAUDERMAN, WILLIAM JAMESSIEGMUND, KIMBERLY D | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $2,003,427 | ZCA1 |
| 2022 | Viral Oncogenesis, Latency, and Replication2P01CA019014-42A1 | DAMANIA, BLOSSOM ARAAB-TRAUB, NANCY JOAN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,936,921 | ZCA1 |
| 2022 | Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment1P01CA272161-01 | STARK, GEORGE ROBERT | CLEVELAND CLINIC LERNER COM-CWRU, OH | $1,916,095 | ZCA1 |
| 2022 | Determining and targeting mechanisms controlling cancer cell division1P01CA254867-01A1 | RUBIN, SETH MICHAELSKOTHEIM, JAN M | STANFORD UNIVERSITY, CA | $1,659,021 | ZCA1 |
| 2022 | Intraoperative Near Infrared Molecular Imaging of Lung Cancer1P01CA254859-01A1 | SINGHAL, SUNIL | UNIVERSITY OF PENNSYLVANIA, PA | $1,638,093 | ZCA1 |
| 2022 | Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis1P01CA268991-01 | EL-RIFAI, WAEL | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $1,574,246 | ZCA1 |
| 2022 | Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies2P01CA214091-06 | RENNE, ROLF F | UNIVERSITY OF FLORIDA, FL | $1,569,513 | ZCA1 |
| 2022 | Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome1P01CA263025-01A1 | EL-SERAG, HASHEM B | BAYLOR COLLEGE OF MEDICINE, TX | $1,562,834 | ZCA1 |
| 2022 | Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response2P01CA084203-17A1 | HASAN, TAYYABAMAYTIN, EDWARD V | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,274,917 | ZCA1 |
| 2022 | In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer1R01CA281361-01 | ROSENBLUTH, JENNIFER M. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $442,767 | ZCA1 |
| 2021 | Structural Cell Biology of DNA Repair Machines2P01CA092584-21 | TAINER, JOHN A. | UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB, CA | $3,043,574 | ZCA1 |
| 2021 | Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.1P01CA261669-01 | HONG, THEODORE SMOHAN, RADHE | MASSACHUSETTS GENERAL HOSPITAL, MA | $2,940,354 | ZCA1 |
| 2021 | Transforming Human Pancreatic Cancer Into An Immunologic Disease1P01CA247886-01A1 | JAFFEE, ELIZABETH M. | JOHNS HOPKINS UNIVERSITY, MD | $2,582,338 | ZCA1 |
| 2021 | Genetics and Biology of Pancreatic Ductal Adenocarcinoma2P01CA117969-16 | DEPINHO, RONALD ANTHONY | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,421,788 | ZCA1 |
| 2021 | Program Project – Improving Provider Announcement Communication Training (IMPACT)1P01CA250989-01A1 | BREWER, NOEL TODD | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $2,381,047 | ZCA1 |
| 2021 | Mechanisms of the BRCA-network in tumorigenesis and therapeutic response1P01CA250957-01A1 | SHEN, ZHIYUAN | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $2,284,926 | ZCA1 |
| 2021 | Pancreatic Cancer Development: Genetic and Immune Regulation1P01CA244114-01A1 | ATTARDI, LAURA DKIM, SEUNG K | STANFORD UNIVERSITY, CA | $2,129,462 | ZCA1 |
| 2021 | Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study2P01CA200512-06 | CUMMINGS, KENNETH MICHAELFONG, GEOFFREY THYLAND, ANDREW | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $2,112,413 | ZCA1 |
| 2021 | Identifying Metabolic Vulnerabilities in Lung Cancer1P01CA250984-01A1 | FLORES, ELSA RHAURA, ERIC B. | H. LEE MOFFITT CANCER CTR & RES INST, FL | $2,060,040 | ZCA1 |
| 2021 | The role of the macroenvironment in pancreatic cancer-induced cachexia1P01CA236778-01A1 | GUTTRIDGE, DENIS C | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $1,954,610 | ZCA1 |
| 2021 | Integrated Immune Engineering for Poor Prognosis Cancers1P01CA254849-01A1 | LARGAESPADA, DAVID ANDREWMASOPUST, DAVIDODDE, DAVID J. | UNIVERSITY OF MINNESOTA, MN | $1,921,029 | ZCA1 |
| 2021 | NORMAL & NEOPLASTIC GROWTH IN THE BRAIN2P01CA096832-16A1 | BAKER, SUZANNE J. | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $1,884,764 | ZCA1 |
| 2021 | NK cells, their receptors and cancer therapy2P01CA111412-16 | MILLER, JEFFREY S. | UNIVERSITY OF MINNESOTA, MN | $1,764,019 | ZCA1 |
| 2021 | Comprehensive dissection of the CLL genome & phenome to improve patient outcomes2P01CA206978-06 | WU, CATHERINE JU-YING | DANA-FARBER CANCER INST, MA | $1,667,862 | ZCA1 |
| 2021 | Mechanisms of Prostate Cancer Metastasis1R01CA271750-01 | FREEMAN, MICHAEL RGARRAWAY, ISLA PEARL | CEDARS-SINAI MEDICAL CENTER, CA | $452,396 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.